Larvol Delta - Overcoming-triple-mutant-EGFRtyrosine-kinase-barriers-in-the-therapeutics-of-nonsmall-cell-lung-cancer-a-patent-review-on-fourthgeneration-inhibitors-20172024

Tagrisso (osimertinib) - AstraZeneca

JIN-A02 - J Ints Bio

BDTX-1535 - Black Diamond Therap

HS-10504 - Jiangsu Hansoh Pharma

http://www.ncbi.nlm.nih.gov/pubmed/40667612

Harun M Patel; Narendra R Nagpure

Jul 17, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next